Sam Possemiers

Sam Possemiers

Company: MRM Health

Job title: Chief Executive Officer


MH002, a 6-strain Optimized Consortium in Clinical Development for Ulcerative Colitis & Pouchitis 12:45 pm

Discover how MH002 was developed through MRM Health’s proprietary CORAL® platform, allowing manufacturing of complete consortia in a single process Reviewing MH002’s multifactorial mechanism-of-action included gut barrier restoration, mucosal healing and immunomodulation  Sharing a status update of both ongoing clinical trials Read more

day: Day One Track B AM

CORAL® Platform as Engine for Design of Optimized Consortia Therapeutics – Therapeutic Program in Spondyloarthritis 12:30 pm

Exploring CORAL® as a bioinformatics-guided in-human discovery engine combined with a breakthrough in optimization and manufacturing of consortia as single drug substance Spondyloarthritis (SpA) is an autoimmune disorder affecting the joints and spine Leveraging on a unique patient cohort, MRM Health is developing a microbial consortium therapeutic for SpA in partnership with the top life…Read more

day: Day Two Track C AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.